Equity Overview
Price & Market Data
Price: $0.424
Daily Change: $0.00 / 0.00%
Daily Range: $0.424 - $0.444
Market Cap: $25,479,558
Daily Volume: 3,901
Performance Metrics
1 Week: -15.41%
1 Month: -11.27%
3 Months: 76.75%
6 Months: 39.31%
1 Year: -81.95%
YTD: -75.90%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country:
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.